Thomas Rowland
Vermögen: 3 Mio $ am 31.07.2026
Vermögen: 3 Mio $ am 31.07.2026
Thomas Andrew Rowland worked at Ventrus Biosciences, Inc. from 2007 to 2012 as Secretary, Director & Chief Business Officer.
Other former positions include Director-Marketing at Aptalis Pharma US, Inc., Marketing Director at Scandipharm, Inc., Vice President-Commercial Development at Alnara Pharmaceuticals, Inc., Vice President-Sales & Marketing at Solvay Pharmaceuticals, Inc., Principal at UCB Pharma, Inc., and Vice President-Commercial Operations at Arbor Pharmaceuticals LLC.
Education includes an undergraduate degree from Metropolitan State University of Denver, conferred in 1989.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products 0.17% | 12.05.2026 | 38’271 ( 0.17% ) | 3 Mio $ | 31.07.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Vorsitzender | 07.11.2011 |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research, development & commercialisation of pharmeceutical and biotechnology products | Corporate Officer/Principal | - |
Scandipharm, Inc.
Scandipharm, Inc. Medical DistributorsDistribution Services Distributes gastrointestinal and nutritional drug products, as well as other products related to the treatment of cystic fibrosis | Vertrieb & Marketing | - |
Arbor Pharmaceuticals LLC
Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on cardiovascular, hospital and pediatric markets | Präsident | - |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Arbor Pharmaceuticals LLC
Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on cardiovascular, hospital and pediatric markets | Health Technology |
Ventrus Biosciences, Inc.
Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets phamaceutical products | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Markets pharmaceutical products for the treatment of gastrointestinal diseases and disorders | Health Technology |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of metabolic diseases | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Scandipharm, Inc.
Scandipharm, Inc. Medical DistributorsDistribution Services Distributes gastrointestinal and nutritional drug products, as well as other products related to the treatment of cystic fibrosis | Distribution Services |
Metropolitan State University of Denver
Metropolitan State University of Denver Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research, development & commercialisation of pharmeceutical and biotechnology products | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen